Top compounds associated with response to MTFR1L


Feature Type Standardized
Nominal ANOVA
mRNA AMG-706 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.013 0.7
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA LY-2157299 CTRPv2 pan-cancer AAC 0.027 0.7
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.013 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV